April 22, 2026

The Data Was Never the Problem: Why Medical Device Safety Keeps Failing the Same Way

Every major medical device safety disaster has a predictable anatomy — and it's the same anatomy as drug safety disasters. From the Dalkon Shield in the 1970s to metal-on-metal hips in the 2000s, from Therac-25's lethal radiation overdoses to Philips' contaminated CPAP machines, the pattern repeats: warning signs existed, the science was available, and no one with authority was accountable to act on it. The device world just has its own particularly insidious ways of letting danger through.
April 20, 2026

Environmental Risk Assessment in Drug Development: What It Is, Why It Matters, and When to Start

A drug can be clinically successful, commercially promising, and still carry an environmental problem nobody planned for. That usually does not show up in the first investor deck. It does not get much airtime in early product meetings. And it definitely does not sound exciting at kickoff. Until it becomes a filing issue.
April 17, 2026

Roadmaps Investors Trust

A founder says the company has a regulatory roadmap. The slide looks polished. The milestones look neat. The dates seem aggressive, but still believable. An investor flips through it and thinks one thing: Can I trust this? That is the real test.
April 16, 2026

How Roadmaps Protect Valuation

A startup can lose value long before anything officially goes wrong. No recall.No warning letter.No failed company announcement. Just growing doubt. An investor starts asking harder […]
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.and Cookie policy
Read more
💬

Chat with us